Abstract
The interaction between proteins and sugars, termed as glycation has been a subject of increasing study over the past decade. The aim of the present study was to investigate the non-enzymatic interaction of thiol- proteinase inhibitor (cystatin) with three reducing sugars glucose, fructose and ribose. The behaviour of glycated cystatin was monitored by change in its hyperchromicity at 280nm, tryptophan fluorescence and Maillard fluorescence. The antipapain activity of glycated cystatin was found to be significantly lower than its non-glycated form. It was found that the incubation of cystatin with all the three sugars led to a parallel decrease in tryptophan fluorescence, enhancement in Maillard fluorescence and hyperchromicity in the UV-region. Among the three sugars studied ribose was found to be the most active in inducing structural and conformational alterations in the protein.
Keywords: Fructose, fluorescence, glycation, glucose, hyperchromicity, liver cystatin, maillard fluorescence, ribose, UV
Current Proteomics
Title:Spectral Methods of Characterizing the Conformational Changes of Glycated Goat Liver Cystatin
Volume: 9 Issue: 4
Author(s): Aaliya Shah, Mohd. Shahnawaz Khan, Medha Priyadarshini, Mohammad Aatif, Fakhra Amin and Bilqees Bano
Affiliation:
Keywords: Fructose, fluorescence, glycation, glucose, hyperchromicity, liver cystatin, maillard fluorescence, ribose, UV
Abstract: The interaction between proteins and sugars, termed as glycation has been a subject of increasing study over the past decade. The aim of the present study was to investigate the non-enzymatic interaction of thiol- proteinase inhibitor (cystatin) with three reducing sugars glucose, fructose and ribose. The behaviour of glycated cystatin was monitored by change in its hyperchromicity at 280nm, tryptophan fluorescence and Maillard fluorescence. The antipapain activity of glycated cystatin was found to be significantly lower than its non-glycated form. It was found that the incubation of cystatin with all the three sugars led to a parallel decrease in tryptophan fluorescence, enhancement in Maillard fluorescence and hyperchromicity in the UV-region. Among the three sugars studied ribose was found to be the most active in inducing structural and conformational alterations in the protein.
Export Options
About this article
Cite this article as:
Shah Aaliya, Shahnawaz Khan Mohd., Priyadarshini Medha, Aatif Mohammad, Amin Fakhra and Bano Bilqees, Spectral Methods of Characterizing the Conformational Changes of Glycated Goat Liver Cystatin, Current Proteomics 2012; 9 (4) . https://dx.doi.org/10.2174/157016412805219215
DOI https://dx.doi.org/10.2174/157016412805219215 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry Statins: A Valuable Tool for the Prevention/Regression of Abdominal Aortic Aneurysms
Vascular Disease Prevention (Discontinued) Factor VIII Levels are Associated with Ischemic Stroke, Stroke Subtypes and Neurological Worsening
Current Neurovascular Research Dissecting the Biological Effects of Isoflurane through the Mechanistic Target of Rapamycin (mTOR) and microRNAs (miRNAs)
Current Neurovascular Research Regulatory Cascade of Neuronal Loss and Glucose Metabolism
CNS & Neurological Disorders - Drug Targets Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Natriuretic Peptides in Coronary Disease With Non-ST Elevation: New Tools Ready for Clinical Application?
Recent Patents on Cardiovascular Drug Discovery Secondary Stroke Prevention with Antithrombotic Drugs
Current Vascular Pharmacology Diabetes-induced Proteome Changes Throughout Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Thrombolysis in Ischemic Stroke: Focus on New Treatment Strategies
Recent Patents on Cardiovascular Drug Discovery Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology A Combined Approach Using Patch-Clamp Study and Computer Simulation Study for Understanding Long QT Syndrome and TdP in Women
Current Cardiology Reviews The Role of PDE5-Inhibitors in Cardiopulmonary Disorders: From Basic Evidence to Clinical Development
Current Medicinal Chemistry Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design HIV-1 Infection: Recent Developments in Treatment and Current Management Strategies
Anti-Infective Agents in Medicinal Chemistry Effects of Evolocumab on Cardiovascular Events
Current Cardiology Reviews Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
Current Pharmaceutical Design Leukocyte Imaging of the Diabetic Foot
Current Pharmaceutical Design Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science Intracranial Atherosclerotic Stenosis is Related to Post-stroke Cognitive Impairment: A Cross-sectional Study of Minor Stroke
Current Alzheimer Research